Oracle Corporation (NYSE:ORCL – Get Free Report) CEO Clayton Magouyrk sold 10,000 shares of the stock in a transaction dated Monday, February 9th. The stock was sold at an average price of $155.23, for a total transaction of $1,552,300.00. Following the sale, the chief executive officer owned 134,030 shares in the company, valued at $20,805,476.90. The trade was a 6.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Oracle Price Performance
Shares of NYSE:ORCL traded down $2.71 during midday trading on Wednesday, hitting $157.18. The stock had a trading volume of 24,506,309 shares, compared to its average volume of 28,218,859. The company’s 50-day moving average price is $187.05 and its 200-day moving average price is $232.85. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 3.28. The company has a market capitalization of $451.61 billion, a P/E ratio of 29.55, a price-to-earnings-growth ratio of 1.37 and a beta of 1.64.
Oracle (NYSE:ORCL – Get Free Report) last posted its quarterly earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.62. Oracle had a net margin of 25.28% and a return on equity of 70.60%. The business had revenue of $16.06 billion for the quarter, compared to analyst estimates of $16.19 billion. During the same quarter last year, the business posted $1.47 EPS. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. As a group, equities research analysts predict that Oracle Corporation will post 5 EPS for the current fiscal year.
Oracle Announces Dividend
Institutional Trading of Oracle
Institutional investors have recently modified their holdings of the business. HFM Investment Advisors LLC boosted its holdings in Oracle by 290.9% in the fourth quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider’s stock valued at $25,000 after acquiring an additional 96 shares during the last quarter. Basepoint Wealth LLC acquired a new position in shares of Oracle in the 4th quarter worth approximately $26,000. Winnow Wealth LLC bought a new stake in shares of Oracle in the 2nd quarter valued at $28,000. FSA Wealth Management LLC bought a new stake in shares of Oracle in the 3rd quarter valued at $28,000. Finally, Joseph Group Capital Management acquired a new stake in shares of Oracle during the fourth quarter worth $29,000. Institutional investors own 42.44% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the stock. Sanford C. Bernstein set a $313.00 target price on shares of Oracle in a report on Monday. BMO Capital Markets lowered their price objective on shares of Oracle from $270.00 to $205.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. William Blair reissued an “outperform” rating on shares of Oracle in a research note on Friday, October 17th. Melius Research set a $160.00 target price on shares of Oracle in a research note on Monday. Finally, Erste Group Bank downgraded shares of Oracle from a “buy” rating to a “hold” rating in a report on Monday, November 10th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Oracle currently has a consensus rating of “Moderate Buy” and a consensus target price of $292.43.
Check Out Our Latest Stock Analysis on ORCL
Oracle News Roundup
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: CMS selects Oracle Cloud Infrastructure to support its modernization initiative — a material federal win that validates OCI for mission‑critical workloads and likely supports backlog and OCI demand. Oracle Cloud Infrastructure to Support Centers for Medicare and Medicaid’s Modernization Initiative
- Positive Sentiment: Oracle rolled out AI agents for Fusion Apps and highlighted strong cloud revenue growth (cloud +34%, RPO surge), reinforcing the company’s AI monetization narrative and recurring SaaS revenue momentum. Oracle Unveils AI Agents for Fusion Apps: Will it Boost Prospects?
- Positive Sentiment: DA Davidson and other firms upgraded ORCL recently, sparking a sharp short‑covering rally earlier in the week and providing a near‑term technical lift. DA Davidson Upgrades Oracle (NYSE:ORCL) to “Buy”
- Positive Sentiment: Renewed optimism around OpenAI exposure (and other AI partner activity) has supported investor sentiment that Oracle can capture meaningful AI cloud demand. Oracle (ORCL) gets fresh boost from optimism around OpenAI exposure
- Neutral Sentiment: Oracle Health customer wins (Hillsboro Health) and other product launches show steady commercial traction in healthcare and supply chain—positive for execution but smaller in near‑term revenue impact. Hillsboro Health Chooses AI-Powered Oracle Health Solutions to Help Advance Patient Care, Optimize Operations
- Neutral Sentiment: Short interest rose in January (shares sold short increased ~19.5% month‑over‑month). That amplifies volatility risk—could fuel squeezes or further downside depending on flows.
- Negative Sentiment: Multiple securities‑fraud class actions and shareholder alerts were filed this week (several law firms notifying investors), creating legal overhang and potential settlement risk that is weighing on the stock. Oracle Corporation Sued for Securities Law Violations – Contact The Gross Law Firm Before April 6, 2026 to Discuss Your Rights – ORCL Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces Lawsuit
- Negative Sentiment: Some sell‑side and media skepticism: Melius downgraded or lowered ratings citing AI monetization uncertainty, and high‑profile commentators flagged balance‑sheet concerns—both contributed to intraday selling pressure. Melius Downgrades Oracle (ORCL) to Hold Jim Cramer on Oracle (ORCL): “I Don’t Like What They’re Doing to Their Balance Sheet”
Oracle Company Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Featured Articles
- Five stocks we like better than Oracle
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
